MRI and IHC of the tumors at 4 weeks after transplantation and 2 weeks after treatment showed a trend toward tumor reduction in the axitinib + sertraline combination group compared with the control, axitinib, and sertraline groups (Figure 6B ).
← all excerpts
New Anti-Angiogenic Therapy for Glioblastoma With the Anti-Depressant Sertraline.
1
—
—